Table 8.
Device | Regular hCG | Hyperglycosylated hCG | hCG Free β | Hyperglycosylated hCG free β | β-subunit core fragment |
A. Point of care devices | |||||
Beckman Icon 25 | + | ? | - | - | - |
Beckman Icon 20 | + | ? | - | - | - |
Beckman Icon II | + | ? | - | - | - |
Inverness Acceava | + | ? | ? | ? | - |
Inverness Clearview | + | ? | ? | ? | - |
Mainline Confirms | + | ? | - | - | - |
Quidel Quick Vue | + | ? | - | - | - |
Quidel Instant Vue | + | ? | - | - | - |
B > Over the counter devices | |||||
Clear Blue Easy | + | ? | + | ? | - |
Clear Blue Easy Digital | + | ? | + | ? | - |
E.P.T. | + | ? | + | ? | - |
E.P.T. Digital | + | ? | + | ? | - |
First Response | + | - | + | + | - |
First Response Digital | + | - | + | + | - |
Devices were tested with a sample containing 2.5 μg/L (100 IU/L) pure β-core fragment and no other form of hCG. Antigens appropriately recognized by assays (detection of standard varies from calibrated concentration by no more than 25%) are indicated by +. Those invariably detected in a specific assay (result more than 50% different from calibrated concentration) are indicated by ?, and those not detected at all are indicted by -.